Mostrar registro simples

dc.contributor.authorBrites, Carlospt_BR
dc.contributor.authorLacerda, Marcus Vinícius Guimarães dept_BR
dc.contributor.authorSprinz, Eduardopt_BR
dc.contributor.authorBay, Mônica Baumgardtpt_BR
dc.contributor.authorPinto, Gustavopt_BR
dc.contributor.authorAzevedo, Pollyanapt_BR
dc.contributor.authorNunes, Ivana Luzpt_BR
dc.contributor.authorMarques, Luzia Estela Menezes Luzpt_BR
dc.contributor.authorNetto, Eduardo Martinspt_BR
dc.date.accessioned2023-03-10T03:24:10Zpt_BR
dc.date.issued2022pt_BR
dc.identifier.issn1758-2652pt_BR
dc.identifier.urihttp://hdl.handle.net/10183/255481pt_BR
dc.format.mimetypeapplication/pdfpt_BR
dc.language.isoengpt_BR
dc.relation.ispartofJournal of the International AIDS Society. Oxfordpt_BR
dc.rightsOpen Accessen
dc.subjectMedicinapt_BR
dc.titleSurvival in advanced AIDS patients treated with efavirenz or dolutegravir in Brazil : a multicenter, observational studypt_BR
dc.typeResumo publicado em eventopt_BR
dc.contributor.eventInternational AIDS Conference (24. : 2022 : Montreal, Canada & Virtual)pt_BR
dc.identifier.nrb001160289pt_BR
dc.type.originEstrangeiropt_BR


Thumbnail
   

Este item está licenciado na Creative Commons License

Mostrar registro simples